Targeting EGFR/HER2/HER3 with a Three-in-One Aptamer-siRNA Chimera Confers Superior Activity against HER2+ Breast Cancer

Autor: Yu, Xiaolin, Ghamande, Sharad, Liu, Haitao, Xue, Lu, Zhao, Shuhua, Tan, Wenxi, Zhao, Lijing, Tang, Shou-Ching, Wu, Daqing, Korkaya, Hasan, Maihle, Nita J., Liu, Hong Yan
Zdroj: In Molecular Therapy - Nucleic Acids 2 March 2018 10:317-330
Databáze: ScienceDirect